D. Vassilopoulos

发表

Individual Drugs in Rheumatology and the Risk of Infection

K. Thomas, D. Vassilopoulos, 2018 .

Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).

C. Tsioufis, C. Stefanadis, D. Vassilopoulos, 2012, International journal of cardiology.

Structural and functional impairment of the retina and optic nerve in Alzheimer's disease.

M. Moschos, S. Papageorgiou, D. Vassilopoulos, 2012, Current Alzheimer research.

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.

D. Vassilopoulos, S. Hadziyannis, V. Sevastianos, 2012, Gastroenterology.

An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment.

E. Frangou, D. Vassilopoulos, D. Boumpas, 2019, Autoimmunity reviews.

Women's health and fertility, family planning and pregnancy in immune-mediated rheumatic diseases: a report from a south-eastern European Expert Meeting.

L. Michala, D. Vassilopoulos, S. Tsiodras, 2014, Clinical and experimental rheumatology.

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study

P. Sfikakis, D. Vassilopoulos, M. Tektonidou, 2021, Rheumatology International.

Prevalence of interatrial block in patients with Friedreich's ataxia.

C. Stefanadis, G. Siasos, M. Panas, 2010, International journal of cardiology.

TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus.

G. Tsokos, D. Vassilopoulos, B. Kovacs, 1995, Journal of immunology.

Immune cell biochemical abnormalities in systemic lupus erythematosus.

G. Tsokos, D. Vassilopoulos, S. Liossis, 1997, Clinical and experimental rheumatology.

NRAMP1 Polymorphism and Viral Factors in Sardinian Multiple Sclerosis Patients

M. Gazouli, L. Sechi, D. Vassilopoulos, 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Evaluation of liver fibrosis by transient elastography (FibroScan®) in rheumatic patients during methotrexate treatment

D. Vassilopoulos, D. Pectasides, S. Manolakopoulos, 2016 .

Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease

A. Giatromanolaki, A. Girod, L. Nakopoulou, 2013, Annals of the rheumatic diseases.

Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3-mediated signal transduction pathway in human T cells.

G. Tsokos, D. Vassilopoulos, R. Rossetti, 1997, Clinical immunology and immunopathology.

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations

K. Thomas, D. Vassilopoulos, C. Koutsianas, 2020, Therapeutic advances in musculoskeletal disease.

Hepatitis B Reactivation in Rheumatic Diseases: Screening and Prevention.

K. Thomas, D. Vassilopoulos, C. Koutsianas, 2017, Rheumatic diseases clinics of North America.

The safety of anti-TNF therapy in patients with hepatitis B and C virus infection

D. Vassilopoulos, G. Papatheodoridis, 2012 .

Clinical Utility of Testing for Antineutrophil Cytoplasmic Antibodies

D. Vassilopoulos, G. Hoffman, 1999, Clinical Diagnostic Laboratory Immunology.

Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients

D. Vassilopoulos, E. Hadziyannis, A. Makris, 2018, Front. Immunol..

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

G. Kitas, P. Sfikakis, A. Drosos, 2017, Clinical and experimental rheumatology.

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

P. Sfikakis, A. Erden, D. Vassilopoulos, 2018, Seminars in arthritis and rheumatism.

FRI0401 Clinical and Financial Burden of SLE in Greece: A Nation-Wide, Multi-Centre Study

P. Sfikakis, A. Drosos, D. Vassilopoulos, 2015 .

Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.

P. Sfikakis, A. Drosos, K. Thomas, 2020, Rheumatology.

Virus-Associated Vasculitides:Clinical Aspects

D. Vassilopoulos, L. Calabrese, 2000 .

Incidence of rotational vertigo in supratentorial stroke: A prospective analysis of 112 consecutive patients

E. Anagnostou, D. Vassilopoulos, K. Spengos, 2010, Journal of the Neurological Sciences.

Vasculitides and Hepatitis C Infection

D. Vassilopoulos, M. Deutsch, 2015 .

HCV Treatments and Their Integration Into Rheumatology

D. Vassilopoulos, L. Calabrese, 2015, Current Rheumatology Reports.

Infections and vasculitis

K. Thomas, D. Vassilopoulos, 2017, Current opinion in rheumatology.

Extrahepatic immunological complications of hepatitis C virus infection.

D. Vassilopoulos, L. Calabrese, 2005, AIDS.

Distribution of muscle fibre types in human skeletal muscle fascicles: an autopsy study of three human muscles.

E. Kararizou, D. Vassilopoulos, P. Manta, 1995, Functional neurology.

Effect of CAG repeat length on psychiatric disorders in Huntington's disease.

E. Vassos, M. Panas, D. Vassilopoulos, 2008, Journal of psychiatric research.

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

K. Thomas, D. Vassilopoulos, D. Boumpas, 2021, Arthritis Research & Therapy.

Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence.

D. Vassilopoulos, A. Fanouriakis, P. Sidiropoulos, 2015, Seminars in arthritis and rheumatism.

REDUCED RAGE mRNA IN MONONUCLEAR BLOOD CELLS OF PATIENTS WITH PROBABLE ALZHEIMER DISEASE

D. Vassilopoulos, E. Tsaltas, C. Nikolaou, 2008, Neurology.

The Byzantine Empress Zoe Porphyrogenita and the quest for eternal youth

M. Panas, D. Vassilopoulos, E. Poulakou-Rebelakou, 2012, Journal of cosmetic dermatology.

Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients

D. Vassilopoulos, C. Poulopoulou, P. Davaki, 2005, Annals of neurology.

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

S. Horton, M. Gianfrancesco, J. Yazdany, 2022, The Lancet Rheumatology.

Changes in LORETA and conventional patterns of P600 after steroid treatment in multiple sclerosis patients

C. Papageorgiou, A. Rabavilas, C. Soldatos, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparison of Two Gamma Interferon Release Assays and Tuberculin Skin Testing for Tuberculosis Screening in a Cohort of Patients with Rheumatic Diseases Starting Anti-Tumor Necrosis Factor Therapy

S. Tsikrika, D. Vassilopoulos, E. Hadziyannis, 2011, Clinical and Vaccine Immunology.

Nucleo-cytoplasmic ratio in ageing skeletal muscle

D. Vassilopoulos, P. Manta, M. Spengos, 2004, European archives of psychiatry and neurological sciences.

Controlling hepatitis C

D. Vassilopoulos, S. Hadziyannis, 2001 .

Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study

P. Sfikakis, P. Voulgari, A. Drosos, 2018, Arthritis Research & Therapy.

Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis

C. Vlachopoulos, C. Stefanadis, D. Vassilopoulos, 2015, Clinical Rheumatology.

Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study.

D. Tousoulis, D. Vassilopoulos, G. Lazaros, 2020, International journal of cardiology.

16 - Hepatitis C Infection and Vasculitis

D. Vassilopoulos, 2004 .

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study

Y. Adler, L. Berkson, G. de Luca, 2019, European journal of preventive cardiology.

The Therapeutic Role of Interleukin-1 Inhibition in Idiopathic Recurrent Pericarditis: Current Evidence and Future Challenges

D. Vassilopoulos, G. Lazaros, Katerina Antonatou, 2017, Front. Med..

Do the Kinetics of Antibody Responses Predict Clinical Outcome in Hospitalized Patients With Moderate-to-Severe COVID-19?

K. Gourgoulianis, D. Vassilopoulos, G. Pavlidis, 2022, In Vivo.

Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019

K. Thomas, D. Vassilopoulos, S. Tsiodras, 2021, Open forum infectious diseases.

Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort study

K. Thomas, D. Vassilopoulos, E. Hadziyannis, 2020, Renal failure.

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit

E. Mirrakhimov, G. Kitas, P. V. van Riel, 2021, RMD Open.

Age‐ and sex‐based differences in patients with acute pericarditis

D. Tousoulis, D. Vassilopoulos, G. Lazaros, 2020, European journal of clinical investigation.

Evidence for seasonal variation in polymyositis.

D. Vassilopoulos, P. Manta, N. Kalfakis, 1989, Neuroepidemiology.

Cytochrome P450 enzyme polymorphisms and treatment-related ovarian toxicity in patients with SLE

D. Vassilopoulos, 2007, Nature Clinical Practice Rheumatology.

A risk score for pericarditis recurrence

C. Tsioufis, D. Tousoulis, K. Toutouzas, 2021, European journal of clinical investigation.

The Role of Colchicine in Pericardial Syndromes.

D. Tousoulis, D. Vassilopoulos, G. Lazaros, 2018, Current pharmaceutical design.

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes

M. Dimopoulos, G. Kitas, P. Sfikakis, 2020, Rheumatology International.

Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study

D. Vassilopoulos, D. Boumpas, P. Sidiropoulos, 2018, Mediterranean journal of rheumatology.

Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases.

E. Kararizou, D. Vassilopoulos, N. Karandreas, 2005, The Journal of rheumatology.

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis

G. Kitas, P. Sfikakis, D. Vassilopoulos, 2020, Mediterranean journal of rheumatology.

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment

K. Thomas, D. Vassilopoulos, E. Hadziyannis, 2020, Pathogens & immunity.

Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha.

G. Tsokos, D. Vassilopoulos, B. Kovacs, 1996, Clinical immunology and immunopathology.

Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections

D. Vassilopoulos, L. Calabrese, 2007, Current opinion in rheumatology.

Patients Scheduled for Anti-Tumor Necrosis Factor Treatment. Addendum Tuberculin Skin Testing for Latent Tuberculosis Screening in Rheumatic Usefulness of Enzyme-Linked Immunosorbent Assay (Elispot) Compared to

D. Vassilopoulos, E. Hadziyannis, Nikolaos Stamoulis, 2017 .

Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.

D. Vassilopoulos, E. Hadziyannis, A. Archimandritis, 2008, The Journal of rheumatology.

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

P. Sfikakis, P. Voulgari, A. Drosos, 2020, Arthritis Research & Therapy.

Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies

K. Thomas, D. Vassilopoulos, 2020, Mediterranean journal of rheumatology.

An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries.

E. Mirrakhimov, G. Kitas, P. V. van Riel, 2021, European heart journal. Cardiovascular pharmacotherapy.

Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases

C. Stefanadis, D. Vassilopoulos, D. Pectasides, 2014, Annals of the rheumatic diseases.

Editorial commentary: Recurrent Pericarditis in the Era of Interleukin-1 Inhibition.

D. Tousoulis, D. Vassilopoulos, G. Lazaros, 2020, Trends in cardiovascular medicine.

Anakinra: an emerging option for refractory idiopathic recurrent pericarditis a systematic review of published evidence

D. Tousoulis, A. Martini, D. Vassilopoulos, 2016, Journal of Cardiovascular Medicine.

Clinical significance of pleural effusions and association with outcome in patients hospitalized with a first episode of acute pericarditis

Y. Adler, C. Stefanadis, D. Tousoulis, 2019, Internal and Emergency Medicine.

Effusive-constrictive pericarditis successfully treated with anakinra.

P. Danias, D. Tousoulis, D. Vassilopoulos, 2015, Clinical and experimental rheumatology.

Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.

E. Cholongitas, D. Vassilopoulos, A. Mentis, 2004, The American journal of medicine.

Development of an ANCA-Associated Vasculitides Patient Registry in Greece

K. Thomas, D. Vassilopoulos, D. Boumpas, 2020, Mediterranean journal of rheumatology.

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study

P. Sfikakis, D. Vassilopoulos, A. Elezoglou, 2022, Mediterranean journal of rheumatology.

Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review.

D. Vassilopoulos, E. Tsochatzis, A. Tasidou, 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece

A. Karlovasitou, D. Vassilopoulos, N. Triantafyllou, 2008, Quality of Life Research.

Tubular aggregates in a patient with primary antiphospholipid syndrome.

D. Vassilopoulos, K. Spengos, P. Manta, 2004, Lupus.

Recommendations Regarding COVID19 Infection in Rheumatic Patients in Greece

D. Vassilopoulos, 2020, Mediterranean journal of rheumatology.

Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease

P. Sfikakis, D. Vassilopoulos, A. Tsolakidis, 2020, RMD open.

ECG changes mimicking myocardial infarction.

C. Tsioufis, C. Stefanadis, D. Vassilopoulos, 2010, The American journal of medicine.

Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases

D. Vassilopoulos, E. Hadziyannis, G. Georgiopoulos, 2014, Annals of the rheumatic diseases.

Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.

D. Vassilopoulos, A. Archimandritis, A. Alexopoulou, 2005, The Journal of rheumatology.

Unusual combination of paraneoplastic manifestations in a patient with metastatic gastrointestinal stromal tumor (GIST)

D. Vassilopoulos, M. Deutsch, S. Manolakopoulos, 2008, Scandinavian journal of gastroenterology.

Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcome.

D. Tousoulis, E. Oikonomou, D. Vassilopoulos, 2019, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

The landscape of acute pericarditis in Greece: Experience from a tertiary referral center.

I. Kallikazaros, C. Stefanadis, D. Tousoulis, 2018, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Plasma testosterone, dehydroepiandrosterone sulfate, and cortisol in female patients with Huntington's disease.

M. Panas, D. Vassilopoulos, M. Markianos, 2007, Neuro endocrinology letters.

Tregs restrain dendritic cell autophagy to ameliorate autoimmunity

L. Boon, A. Ghigo, K. Cadwell, 2017, The Journal of clinical investigation.

Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies

K. Thomas, D. Vassilopoulos, D. Boumpas, 2020, Mediterranean Journal of Rheumatology.

Long-Term Effect on Health-Related Quality of Life in Patients With COVID-19 Requiring Hospitalization Compared to Non-hospitalized COVID-19 Patients and Healthy Controls

D. Vassilopoulos, D. Niakas, G. Fragkiadakis, 2022, Cureus.

Study of the natural course and specific immunity after herpes zoster in patients with rheumatoid arthritis receiving biologic DMARDs

P. Sfikakis, K. Thomas, D. Vassilopoulos, 2017, Mediterranean journal of rheumatology.

Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.

D. Vassilopoulos, M. Anastasiou-Nana, E. Tsagalou, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

TGF-β1/Smad Signalling in Proliferative Glomerulonephritis Associated with Autoimmune Diseases

D. Vassilopoulos, P. Foukas, D. Petras, 2022, Mediterranean journal of rheumatology.

Hepatitis C Virus (HCV)-Related Cryoglobulinemia: Cryoglobulin Type and Anti-HCV Profile

D. Vassilopoulos, J. Koskinas, E. Hadziyannis, 2013, Clinical and Vaccine Immunology.

Can Nucleos(t)ide Analogue (NA) Therapy Ever be Stopped in HBeAg-Negative Chronic Hepatitis B?

D. Vassilopoulos, S. Hadziyannis, V. Sevastianos, 2014, Current Hepatology Reports.

What Should Be the Endpoints of Oral Therapy in HBeAg-positive Versus HBeAg-negative Patients with Chronic Hepatitis B

D. Vassilopoulos, S. Hadziyannis, 2012, Current Hepatitis Reports.

Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes.

D. Vassilopoulos, 2011, European journal of internal medicine.

Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study.

I. Kallikazaros, C. Tsioufis, C. Stefanadis, 2014, International journal of cardiology.

Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs

P. Sfikakis, D. Vassilopoulos, P. Sidiropoulos, 2019, Mediterranean journal of rheumatology.

Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.

P. Sfikakis, D. Vassilopoulos, E. Vritzali, 2016, Clinical and experimental rheumatology.

Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases

P. Sfikakis, D. Bogdanos, P. Voulgari, 2021, Annals of the Rheumatic Diseases.

Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis

G. Kitas, P. Sfikakis, P. Voulgari, 2023, Frontiers in Medicine.

Musculoskeletal Infections in Patients with Human Immunodeficiency Virus Infection

K. Workowski, D. Vassilopoulos, C. Agudelo, 1997, Medicine.

The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study

D. Psaltis, D. Vassilopoulos, L. Settas, 2022, Rheumatology International.

Selected drug complications and treatment conflicts in the presence of coexistent diseases.

D. Vassilopoulos, C. Camisa, R. Strauss, 1999, Rheumatic diseases clinics of North America.

Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection

D. Vassilopoulos, L. Calabrese, N. Zein, 2004, Annals of the rheumatic diseases.

Reflex sympathetic dystrophy syndrome and osteogenesis imperfecta. A report and review of the literature.

D. Vassilopoulos, D. Karras, G. Karargiris, 1993, The Journal of rheumatology.

The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis

C. Vlachopoulos, D. Tousoulis, N. Ioakeimidis, 2018, Clinical Rheumatology.

Hepatitis B e antigen–negative chronic hepatitis B

D. Vassilopoulos, S. Hadziyannis, 2001, Hepatology.

Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia

M. Panas, D. Vassilopoulos, Dimitrios Vassilopoulos, 2005, Annals of neurology.

Higher Levels of Extroverted Hostility Detected in Gene Carriers at Risk for Huntington’s Disease

E. Vassos, M. Panas, D. Vassilopoulos, 2007, Biological Psychiatry.

Telbivudine in the treatment of chronic hepatitis B

D. Vassilopoulos, S. Hadziyannis, 2008, Expert review of gastroenterology & hepatology.

The natural course of chronic hepatitis B virus infection and its management.

D. Vassilopoulos, S. Hadziyannis, E. Hadziyannis, 2013, Advances in pharmacology.

Treatment of HBeAg-negative chronic hepatitis B.

D. Vassilopoulos, S. Hadziyannis, G. Papatheodoridis, 2003, Seminars in liver disease.

Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.

D. Vassilopoulos, M. Deutsch, S. Manolakopoulos, 2011, European journal of gastroenterology & hepatology.

Management of rheumatic disease with comorbid HBV or HCV infection

D. Vassilopoulos, L. Calabrese, 2012, Nature Reviews Rheumatology.

Viral Hepatitis: Review of Arthritic Complications and Therapy for Arthritis in the Presence of Active HBV/HCV

D. Vassilopoulos, L. Calabrese, 2013, Current Rheumatology Reports.

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

D. Vassilopoulos, L. Calabrese, N. Zein, 2006, Annals of the rheumatic diseases.

Performance Characteristics of Microparticle Enzyme and Chemiluminescence Immunoassays for Measurement of Anti-HBc Immunoglobulin M in Sera of Patients with HBeAg-Negative Chronic Hepatitis B Virus Infection

D. Vassilopoulos, A. Georgiou, E. Hadziyannis, 2007, Clinical and Vaccine Immunology.

Complex management issues: management of HCV in the atypical patient.

D. Vassilopoulos, S. Hadziyannis, Dimitrios Vassilopoulos, 2000, Bailliere's best practice & research. Clinical gastroenterology.

High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.

P. Sfikakis, P. Voulgari, A. Drosos, 2018, Clinical and experimental rheumatology.

Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients

G. Kitas, P. Sfikakis, A. Drosos, 2018, Mediterranean journal of rheumatology.

Quantitative HBsAg titer as predictor of response to therapy

D. Vassilopoulos, S. Hadziyannis, E. Hadziyannis, 2009 .

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

D. Vassilopoulos, J. Koskinas, E. Hadziyannis, 2010, Annals of the rheumatic diseases.

Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection.

D. Vassilopoulos, S. Hadziyannis, 2001, Antiviral research.

Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents

K. Thomas, D. Vassilopoulos, E. Hadziyannis, 2021, Journal of viral hepatitis.

Current treatment options for HBV infection

D. Vassilopoulos, S. Hadziyannis, 2009 .

Prevention of HBV reactivation in patients treated with biologic agents

K. Thomas, D. Vassilopoulos, C. Koutsianas, 2016, Expert review of clinical pharmacology.

Size and proportion of fiber types in human muscle fascicles.

E. Kararizou, D. Vassilopoulos, C. Papageorgiou, 1996, Clinical neuropathology.

The Complex Management of Viral-Related Autoimmune Diseases

D. Vassilopoulos, S. Manolakopoulos, 2011 .

Virus‐Associated Vasculitides

D. Vassilopoulos, L. Calabrese, 2012 .

Rheumatic manifestations of hepatitis C infection

D. Vassilopoulos, L. Calabrese, 2003, Current rheumatology reports.

High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma.

G. Orfanoudakis, D. Vassilopoulos, J. Koskinas, 2011, The Journal of general virology.

Immunization in patients with inflammatory rheumatic diseases.

K. Thomas, D. Vassilopoulos, 2016, Best practice & research. Clinical rheumatology.

Lack of visual evoked potential habituation in the syndrome of HaNDL

E. Anagnostou, D. Vassilopoulos, K. Spengos, 2009, Journal of Neurology.

Editorial: Infection-Related Rheumatic Diseases

K. Thomas, D. Vassilopoulos, C. Calabrese, 2021, Frontiers in Medicine.

Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations.

R. Kimberly, Z. Younossi, D. Vassilopoulos, 2003, Clinical and experimental rheumatology.

Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b

D. Vassilopoulos, E. Hadziyannis, M. Deutsch, 2007, Scandinavian journal of gastroenterology.

Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies.

D. Vassilopoulos, L. Calabrese, 2002, Arthritis and rheumatism.

Recurrent ventricular arrhythmia in a patient with aortitis and myocardial inflammation due to possible immunoglobulin G4‐related disease

D. Tousoulis, K. Thomas, D. Vassilopoulos, 2018, Internal medicine journal.

Myelodysplastic syndrome presenting as acquired ichthyosis.

D. Vassilopoulos, E. Tsochatzis, M. Deutsch, 2006, European journal of internal medicine.

Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studies

K. Thomas, D. Vassilopoulos, E. Hadziyannis, 2023, Rheumatology International.

Ixekizumab therapy following secukinumab inadequate response in psoriatic arthritis: a case series focusing on axial disease

P. Sfikakis, D. Vassilopoulos, M. Tektonidou, 2023, Rheumatology International.

Rheumatic manifestations of hepatitis

D. Vassilopoulos, S. Manolakopoulos, 2010, Current opinion in rheumatology.

Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations

D. Vassilopoulos, L. Calabrese, 2008, Arthritis research & therapy.

Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.

M. Michalopoulou, A. Tavernarakis, D. Vassilopoulos, 2004, Immunology letters.

Increased plasma homocysteine levels in patients with multiple sclerosis and depression

C. Nikolaou, V. Kimiskidis, C. Sfagos, 2008, Annals of general psychiatry.

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection

D. Vassilopoulos, E. Hadziyannis, A. Kandili, 2012, Annals of the rheumatic diseases.

Effects of an aminosteroid inhibitor of phospholipase C-dependent processes on the TCR-mediated signal transduction pathway in human T cells.

R. Smallridge, G. Tsokos, D. Vassilopoulos, 1995, Clinical immunology and immunopathology.

Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B

D. Vassilopoulos, S. Hadziyannis, I. Rapti, 2008, Journal of viral hepatitis.

Transforming Growth Factor-β1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease

D. Vassilopoulos, P. Foukas, D. Petras, 2021, American Journal of Nephrology.

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

P. Merkel, A. Vaglio, O. Karadag, 2023, Annals of the Rheumatic Diseases.

Pneumocystis Jirovecii Pneumonia after Initiation of Tofacitinib Therapy in Rheumatoid Arthritis: Case-Based Review

K. Thomas, D. Vassilopoulos, M. Deutsch, 2019, Mediterranean journal of rheumatology.

Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction.

P. Merkel, A. Arroliga, D. Vassilopoulos, 2003, Arthritis and rheumatism.

AB0633 Health-Related Quality of Life in ANCA Vasculitides and Rheumatoid Arthritis patients: a cross-sectional comparative study

K. Thomas, D. Vassilopoulos, E. Argyriou, 2022, Annals of the Rheumatic Diseases.

SAT0247 FEMALE SEX AND AGE AT DIAGNOSIS ARE ASSOCIATED WITH A DECREASED POSSIBILITY OF DRUG DISCONTINUATION IN GIANT CELL ARTERITIS: DATA FROM A MULTICENTER PROSPECTIVE COHORT OF 177 PATIENTS

P. Sfikakis, P. Voulgari, D. Vassilopoulos, 2019, Saturday, 15 June 2019.

Morphological and morphometrical study of human muscle spindles in Werdnig-Hoffmann disease (infantile spinal muscular atrophy type I).

E. Kararizou, D. Vassilopoulos, N. Kalfakis, 2006, Acta histochemica.

Morphometric study of the human muscle spindle.

E. Kararizou, D. Vassilopoulos, P. Manta, 2005, Analytical and quantitative cytology and histology.

Nonepisodic Memory Deficits in Amnestic MCI

Alexandra Economou, Sokratis G. Papageorgiou, A. Economou, 2007, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases?

S. Mavrogeni, D. Vassilopoulos, 2011, Seminars in arthritis and rheumatism.

Cochlear Function in Facioscapulohumeral Muscular Dystrophy

D. Vassilopoulos, D. Balatsouras, A. Panousopoulou, 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States

C. Tsioufis, C. Anastassopoulou, A. Tsakris, 2021, Vaccine.

Acute splenic sequestration crisis (ASSC) in an adult patient with β-thalassemia sickle cell disease: a life-threatening complication

D. Vassilopoulos, E. Tsochatzis, M. Deutsch, 2008, Annals of Hematology.

Patients’ and Doctors’ Beliefs about Treatment and Long-Term Adherence in Rheumatic Diseases

J. Yfantopoulos, D. Vassilopoulos, M. Protopapa, 2020, Mediterranean journal of rheumatology.

Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognition.

C. Nikolaou, E. Kararizou, D. Vassilopoulos, 2008, Parkinsonism & related disorders.

Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need?

C. Kallenberg, H. Lamb, G. Kitas, 2018, Clinical and experimental rheumatology.

Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international audit

E. Mirrakhimov, G. Kitas, P. V. van Riel, 2022, International journal of cardiology. Heart & vasculature.

The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus

K. Thomas, D. Vassilopoulos, D. Boumpas, 2023, Frontiers in Immunology.

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

S. Horton, M. Gianfrancesco, J. Yazdany, 2021, The Lancet Rheumatology.

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy

D. Vassilopoulos, E. Tsochatzis, E. Hadziyannis, 2007, Scandinavian journal of gastroenterology.

Aberrant modulation of a delayed rectifier potassium channel by glutamate in Alzheimer's disease

A. Rombos, D. Vassilopoulos, A. Hatzimanolis, 2010, Neurobiology of Disease.

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study

P. Sfikakis, K. Thomas, D. Vassilopoulos, 2021, Rheumatology International.

Severe pancytopenia and splenomegaly associated with felty's syndrome, both fully responsive solely to corticosteroids

D. Vassilopoulos, S. Dourakis, George D. Liatsos, 2018, Clinical case reports.

Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients

G. Kitas, P. Sfikakis, A. Drosos, 2020, Therapeutic advances in musculoskeletal disease.

Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign

D. Vassilopoulos, L. Koutsogeorgopoulou, C. Antoniadis, 2008, Clinical Rheumatology.

Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology–Rheumatology clinic: a retrospective real-world study

D. Rigopoulos, D. Vassilopoulos, Maria Stavropoulou, 2022, Rheumatology International.

SAT0176 Patterns of biologic dmard monotherapy in a large nationwide rheumatoid arthritis cohort: data from 1036 patients

K. Thomas, D. Vassilopoulos, T. Dimitroulas, 2017 .

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting

E. Terpos, D. Vassilopoulos, A. Andrikopoulou, 2023, The breast journal.

Reversible Epstein-Barr virus associated T cell non-Hodgkin's lymphoma in a patient with rheumatoid arthritis undergoing chronic immunosuppressive therapy.

D. Vassilopoulos, M. Fanucchi, J. Waltuck, 1998, The Journal of rheumatology.

Influence of sleep disturbance on quality of life of patients with epilepsy

A. Karlovasitou, D. Vassilopoulos, T. Constantinidis, 2008, Seizure.

Clinical Features of Hepatitis Delta Virus

D. Vassilopoulos, S. Hadziyannis, 2006 .

Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience.

D. Vassilopoulos, G. Fragoulis, A. Iliopoulos, 2020, Rheumatology.

Toward understanding cognitive impairment in patients with myotonic dystrophy type 1.

S. Papageorgiou, I. Zalonis, D. Vassilopoulos, 2010, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Modulation of voltage-gated potassium channels in human T lymphocytes by extracellular glutamate.

D. Vassilopoulos, Alexandros Poulopoulos, C. Nikolaou, 2004, Molecular pharmacology.

A case of adenoviral covid-19 vector vaccine possibly linked to severe but reversible interstitial lung injury post-vaccination

D. Vassilopoulos, M. Karmpalioti, A. Mavroudis, 2022, Infectious diseases.

AB0678 ANTIPROLIFERATIVE AND VASOACTIVE TREATMENT MODALITIES IN 457 CONSECUTIVE PATIENTS WITH SYSTEMIC SCLEROSIS FROM ACADEMIC CENTERS IN GREECE

P. Sfikakis, P. Voulgari, A. Drosos, 2019, Abstracts accepted for Publication.

Correlation of patient preferences to treatment outcomes in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors in Greece

A. Drosos, D. Vassilopoulos, P. Sidiropoulos, 2020, Clinical Rheumatology.

Lamotrigine Withdrawal may Worsen RBD Symptoms

L. Ferini-Strambi, N. Economou, D. Vassilopoulos, 2011, The neurologist.

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis

K. Thomas, D. Vassilopoulos, A. Lazarini, 2020, Frontiers in Medicine.

Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective study

P. Sfikakis, D. Bogdanos, P. Voulgari, 2023, Rheumatology International.

110 – Rheumatologic aspects of viral infections

D. Vassilopoulos, L. Calabrese, 2015 .

Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.

D. Vassilopoulos, E. Hadziyannis, A. Archimandritis, 2008, Journal of Rheumatology.

Cognitive dysfunction in non-demented patients with Parkinson's disease

M. Anagnostouli, I. Zalonis, E. Kararizou, 2010, Annals of General Psychiatry.

Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.

G. Kitas, P. Sfikakis, P. Voulgari, 2020, Rheumatology.

Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2

K. Thomas, D. Vassilopoulos, S. Tsiodras, 2023, Rheumatology.

Reference data for derived Trail Making Test scores in Greek healthy population

I. Zalonis, E. Kararizou, D. Vassilopoulos, 2010, Annals of General Psychiatry.

2019 EULAR points to consider for the assessment of competences in rheumatology specialty training

M. Dougados, A. Iagnocco, G. Burmester, 2020, Annals of the Rheumatic Diseases.

Clinical and financial burden of active lupus in Greece: a nationwide study

P. Sfikakis, A. Drosos, D. Vassilopoulos, 2016, Lupus.

Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.

D. Vassilopoulos, D. Boumpas, A. Fanouriakis, 2014, Rheumatology.

Hashimoto Encephalopathy with Pegylated Interferon Alfa-2b and Ribavirin

D. Vassilopoulos, G. Tolis, J. Koskinas, 2005, The Annals of pharmacotherapy.

Plasma Homovanillic Acid and Prolactin in Huntington’s Disease

M. Panas, D. Vassilopoulos, M. Markianos, 2009, Neurochemical Research.

Real-Time PCR Analysis of Trinucleotide Repeat Allele Expansions in the Androgen Receptor Gene

C. Yapijakis, I. Georgiou, D. Vassilopoulos, 2012, Molecular Diagnosis.

AN EDITION OF GREEK RHEUMATOLOGY SOCIETY AND PROFESSIONAL ASSOCIATION OF RHEUMATOLOGISTS

R. Moots, A. Iagnocco, E. Naredo, 2017 .

Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study

D. Psaltis, D. Vassilopoulos, M. Tektonidou, 2023, Rheumatology International.

Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology.

D. Vassilopoulos, A. Drosos, D. Vassilopoulos, 2008, Clinical and experimental rheumatology.

Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases

D. Vassilopoulos, E. Hadziyannis, G. Georgiopoulos, 2014, Annals of the Rheumatic Diseases.

A. Giatromanolaki, A. Girod, L. Nakopoulou, 2013, Annals of the rheumatic diseases.

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.

D. Vassilopoulos, S. Hadziyannis, V. Sevastianos, 2012, Gastroenterology.

Anakinra: an emerging option for refractory idiopathic recurrent pericarditis a systematic review of published evidence

D. Tousoulis, A. Martini, D. Vassilopoulos, 2016, Journal of cardiovascular medicine.

The natural course of chronic hepatitis B virus infection and its management.

D. Vassilopoulos, S. Hadziyannis, E. Hadziyannis, 2013, Advances in pharmacology.

Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases

C. Stefanadis, D. Vassilopoulos, D. Pectasides, 2014, Annals of the rheumatic diseases.

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies

D. Vassilopoulos, C. Mavragani, Charalampos Skarlis, 2023, Mediterranean journal of rheumatology.

Interleukin-1 blockade for recurrent pericarditis: Insights from the real-world experience.

D. Vassilopoulos, M. Gattorno, A. Insalaco, 2023, The Journal of pediatrics.